Preparation method of oxazepine compound
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- 푸지엔에이키링크바이오테크놀로지컴퍼니리미티드
- Publication Date
- 2021-02-23
Smart Images
Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to a preparation method of oxazepine compounds. Background technique
[0002] Hepatitis B virus, referred to as hepatitis B, is a disease caused by hepatitis B virus (Hepatitis B Virus, HBV) infection after the body. Hepatitis B virus is a hepatotropic virus that mainly exists in liver cells and damages liver cells, causing inflammation, necrosis, and fibrosis of liver cells. There are two types of hepatitis B: acute and chronic. Most acute hepatitis B can be cured by its own immune mechanism in adults. However, chronic hepatitis B (CHB) has become a great challenge to global health care, and it is also the main cause of chronic liver disease, cirrhosis and hepatocellular carcinoma (HCC). It is estimated that 2 billion people in the world are infected with chronic hepatitis B virus, more than 350 million people have developed into hepatitis B, and nearly 600,000 people die of complications of chronic hepatitis B every year. my...